Skip to main content
Ying Taur, MD, Infectious Disease, New York, NY, Memorial Sloan Kettering Cancer Center

YingTaurMDMPH

Infectious Disease New York, NY

Transplant/Immunocompromised States

Assistant Attending, Medicine, Weill Cornell Medical College

Dr. Taur is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Taur's full profile

Already have an account?

Summary

  • Dr. Ying Taur is an infectious disease specialist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from New York Medical College and has been in practice 14 years. He specializes in transplant/immunocompromised states.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Infectious Disease, 2006 - 2009
  • Zucker School of Medicine at Hofstra/Northwell
    Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2003 - 2006
  • New York Medical College
    New York Medical CollegeClass of 2003

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2006 - 2026
  • American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Journal Articles

  • Gut Microbiota Dysbiosis and Diarrhea in Kidney Transplant Recipients  
    Eric Pamer, Manikkam Suthanthiran, Ying Taur, Michael J Satlin, Darshana Dadhania, John Richard Lee, Carl Crawford, Michelle Lubetzky, American journal of transplantation

Abstracts/Posters

  • Antibiotic Exposures and Dietary Intakes Are Associated with Changes in Microbiota Compositions in Allogeneic Hematopoietic Stem Cell Transplant Patients
    Ying Taur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Sparing of the Lower Gastrointestinal Tract Microbiota Is Associated with Reduced Acute Graft-Versus-Host Disease
    Ying Taur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • The Blood Microbiome Predicts Acute Graft-Versus-Host Disease after Stem Cell Transplantation
    Ying Taur, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Press Mentions

  • Cancer Immunotherapy Tied to Severe COVID-19 Outcomes
    Cancer Immunotherapy Tied to Severe COVID-19 OutcomesJune 25th, 2020
  • Should You Delay Cancer Treatment Because of COVID-19? Study Says Most Treatments Don’t Worsen Coronavirus Infection
    Should You Delay Cancer Treatment Because of COVID-19? Study Says Most Treatments Don’t Worsen Coronavirus InfectionJune 24th, 2020

Hospital Affiliations